New product: Inrebic (fedratinib) 100 mg hard capsules

This is licensed for treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis, who are JAK inhibitor naïve or have been treated with ruxolitinib.

Source:

electronic Medicines compendium